CBS 2019
CBSMD教育中心
中 文

推荐文献

Abstract

Recommended Article

Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance Document Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial The Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study) Coronary Artery Calcium Progression Is Associated With Coronary Plaque Volume Progression - Results From a Quantitative Semiautomated Coronary Artery Plaque Analysis

Clinical Trial2020 Sep 7;41(34):3239-3252.

JOURNAL:Eur Heart J. Article Link

Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction

TJ Ford, D Corcoran, S Padmanabhan et al. Keywords: coronary microvascular dysfunction; endothelin-1; microvascular angina; precision medicine; single-nucleotide polymorphism; stable angina pectoris

Full Text PDF